Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,636 GBX | -0.91% | +2.89% | +12.81% |
Apr. 24 | CureVac Begins Early Stage Portion of Investigational Vaccine Trial | MT |
Apr. 24 | Global markets live: Heineken, AT&T Hasbro, Visa, Boeing... |
Evolution of the average Target Price on GSK plc
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering GSK plc
Barclays | |
BERENBERG | Kerry Holford |
JPMORGAN | James Gordon |
UBS | |
JEFFERIES | Peter Welford |
Guggenheim | |
DEUTSCHE BANK RESEARCH | Emmanuel Papadakis |
Citigroup | |
Jefferies & Co. | |
Deutsche Bank Securities | |
alphavalue | Abhishek Raval |
DZ BANK | Elmar Kraus |
Morgan Stanley | |
Berenberg Bank | |
CREDIT SUISSE | Dominic Lunn |
HSBC | |
GOLDMAN SACHS | Keyur Parekh |
Bank of America Securities/Merrill Lynch | |
Stifel Nicolaus | |
ODDO BHF | |
Societe Generale | |
Liberum Capital | |
J.P. Morgan Chase | |
DEUTSCHE BANK | Emmanuel Papadakis |
KEPLER CHEUVREUX | David Evans |
BAADER BANK | |
SVB Leerink | |
LBBW | |
BANK OF AMERICA (BOFA) | Graham Parry |
EPS Revisions
- Stock Market
- Equities
- GSK Stock
- Consensus GSK plc